ToxBank supports a wide diversity of experimental and modelling activities carried out by 75 organisations within the SEURAT-1 research cluster, which is developing replacement alternatives for safety assessment.
SEURAT-1 is a public-private partnership funded by Cosmetics Europe and the EC.
ToxBank provides a unique combination of people and scalable infrastructure enabling Complex (Big Data) Omics Analysis. Come and discuss with us at #sot2014#opentox#toxbank#toxexpo Demos at Douglas Connect Stand 1770 #opentox
Dear Republicans and Democrats:
Can you please learn to collaborate and reopen the US goverment asap? I
am currently working on developing international collaboration on
safety with US scientists and we have a really promising meeting planned
for end of October to interact on. But currently many of them are now
furloughed and our progress has been brought to a standstill. Can't we
have intelligent discussion and negotiations without paralysis of useful
actions we are trying to progress in the US and internationally?
The background of developing Open Standards, Open Specifications and related Open Source Components with OpenTox provides a valuable foundation on which we are developing ToxBank as a reference extensible architecture for predictive toxicology.
I suggested OpenTox is developing itself as an Open Knowledge Community supporting accelerating innovation through knowledge sharing, application development, semantic interoperability and ontology for combining data and models, and learning from the application of developed tools to problem solving.
We are interacting with many partners on the SEURAT-1 program providing a rich context for requirements gathering, design and implementation, working closely with the evolving needs and development goals of the program.
We have been working on putting in place best practices on the description of data, and importantly the protocols used to generate and process that data.
I suggested it is also a priority that this practice includes the contributions of computational science and integrated analysis, and I encouraged both the OpenTox community and the ToxBank development to progress this important goal.
The above approaches provide a foundation on which we can integrate many advances in integrated analysis, systems biology, in vitro assay development, omics, and bioengineeering to support an event driven Weight of Evidence approach and semantic reasoning across ontology-linked heterogenous evidence.
You can download a copy of the slides here as a pdf:
We will be joined by presenters from many leading US research programs
including ToxCast, Tox21, US EPA, NIEHS, NTP, NIH, US FDA, Risk21,
Hamner and John Hopkins.
The meeting is organised in collaboration with ToxBank and will include
participation from SEURAT-1 European research programs including
HeMiBio, COSMOS, NOTOX, and ToxBank.
The meeting should provide a valuable opportunity to progress transatlantic goals on interoperability and collaboration supporting
SEURAT-1 - Tox21 interactions based on concrete activities related to data resource interoperability, open standards, software development,
modelling and integrated analysis.
We will also specifically address key îssues of extrapolation, kinetics modelling and risk assessment application providing roadblocks to be
removed from the path to regulatory acceptance.